Molecular pathogenesis of tuber formation in tuberous sclerosis complex (Q35962478)

11 August 2017

1 reference

title

Molecular pathogenesis of tuber formation in tuberous sclerosis complex (English)

1 reference

11 August 2017

1 reference

1 reference

Peter B Crino

1

1 reference

11 August 2017

publication date

1 September 2004

1 reference

Journal of Child Neurology

11 August 2017

published in

1 reference

11 August 2017

volume

19

1 reference

11 August 2017

issue

9

1 reference

11 August 2017

page(s)

716-725

1 reference

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Identification and characterization of the tuberous sclerosis gene on chromosome 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Evidence of abnormal differentiation in giant cells of tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Fine structure of cortical tubers in tuberous sclerosis: a Golgi study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Immunohistochemical characterization of subependymal giant cell astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

CD44 expression in tuberous sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Markers of cellular proliferation are expressed in cortical tubers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Surgical treatment of epilepsy in tuberous sclerosis: strategies and results in 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Cortical tubers demonstrate reduced immunoreactivity for synapsin I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

A role of the tuberous sclerosis gene-2 product during neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

New developments in the neurobiology of the tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

TOR, a central controller of cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

White matter abnormalities in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

TSC1–TSC2: a complex tale of PKB-mediated S6K regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/08830738040190091301

10.1177/08830738040190091301

21 January 2018

Identifiers

DOI

0 references

1 reference